EGFL7 anticorps

N° du produit ABIN1589865

Détail du produit anti-EGFL7 anticorps

Antigène: EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EGFL7 est non-conjugé

Application: Western Blotting (WB)

Fonction: VE-Statin/EGFL7 antibody

Specificité: Recombinant mouse EGFL-7

Attributs du produit: Chromosomal location: 2, 2 B
Produced from sera of rabbits immunized with highly pure recombinant mouse EGFL-7derived from E. Coli.

Purification: Protein A purified

Immunogène: Recombinant mouse EGFL7

Isotype: IgG

Information d'application

Indications d'application: Western Blot: use at 1-5 μg/mL.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

Buffer: PBS

Conseil sur la manipulation: Centrifuge vial prior to opening.

Stock: 4 °C,-20 °C

Stockage commentaire: The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.

Date de péremption: 24 months

Détails sur EGFL7

Antigène: EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))

Autre désignation: VE-Statin/EGFL7 (EGFL7 Produits)

Synonymes: anticorps egfl7, anticorps MGC53105, anticorps EGFL7, anticorps zgc:136669, anticorps zgc:152804, anticorps zneu1, anticorps xegfl7, anticorps MGC147423, anticorps VE-statin, anticorps Zneu1, anticorps NEU1, anticorps RP11-251M1.2, anticorps VE-STATIN, anticorps ZNEU1, anticorps EGF like domain multiple 7 S homeolog, anticorps EGF like domain multiple 7, anticorps EGF-like-domain, multiple 7, anticorps EGF-like domain 7, anticorps egfl7.S, anticorps EGFL7, anticorps egfl7, anticorps Egfl7

Sujet: Egfl7, EGF-like domain 7, Zneu1, VE-statin,EGFL7 is an ~ 30 kDa secreted protein that contain an Emilin-like (EMI) domain (a multimerization motif), and 2 epidermal growth factor (EGF) domains, one of which binds calcium. Based on these domains, it has been hypothesized that EGFL7 may self-assemble like extracellular matrix (ECM) proteins and, thus, could incorporate into ECM. EGFL7 has been reported to stimulate cell adhesion as well as motility in a manner similar to ECM proteins. EGFL7 has been shown to be primarily expressed by developing ECs but also by primordial germ cells and some central nervous system neurons. Interestingly, EGFL7 expression markedly decreases in ECs in postnatal life, but can be strongly up-regulated after various tissue injuries that lead to increased angiogenic responses.

ID gène: 353156

NCBI Accession: NM_198725, NP_942018

UniProt: Q9QXT5